COMMUNIQUÉS West-GlobeNewswire
-
Mesoblast Reports Ryoncil® Net Revenues of US$36M for the Quarter and US$115M for First Full Year of Product Launch
30/07/2026 -
Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas
30/07/2026 -
BRAVE Providers, LLC Launches The BRAVE Method, an Organizational Training Program Addressing Vicarious Trauma and Resilience in Trauma-Exposed Organizations
30/07/2026 -
FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.
29/07/2026 -
Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares and/or Pre-Funded Warrants
29/07/2026 -
Inventiva annonce ses résultats financiers préliminaires pour le premier semestre 2026¹
29/07/2026 -
Inventiva Announces Preliminary Financial Results for the First Half of 2026¹
29/07/2026 -
MIMEDX to Acquire Sanara MedTech
29/07/2026 -
Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance
29/07/2026 -
60 Degrees Pharmaceuticals Announces Minimum Enrollment Achieved in Hospitalized Babesiosis Study; Interim Data Readout Planned by October 6, 2026
29/07/2026 -
Teladoc Health Reports Second Quarter 2026 Results
29/07/2026 -
Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results
29/07/2026 -
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
29/07/2026 -
Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026
29/07/2026 -
OrthoPediatrics to Participate in the Canaccord Genuity 46th Annual Growth Conference
29/07/2026 -
BioStem Technologies to Host Second Quarter 2026 Financial Results Conference Call on August 12, 2026
29/07/2026 -
Revolution Medicines to Report Financial Results for Second Quarter 2026 After Market Close on August 5, 2026
29/07/2026 -
MIMEDX Announces Second Quarter 2026 Operating & Financial Results
29/07/2026 -
DLH Reports Fiscal 2026 Third Quarter Results
29/07/2026
Pages